2021 Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Johanna Waidhauser Journal Bone Marrow Transplant.
2021 Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Maria H Gilleece Journal Blood Cancer J.
2021 Feasibility and Outcomes of a Third Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Andreas Rank Journal Transplant Cell Ther.
2021 Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Mohamed A Kharfan-Dabaja Journal Bone Marrow Transplant.
2021 Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic Leukemia Group Acute Leukemia Working Party (ALWP) 1st listed author Bhagirathbhai Dholaria Journal Transplant Cell Ther.
2021 Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia Group Acute Leukemia Working Party (ALWP) 1st listed author Mohamed A Kharfan-Dabaja Journal Br J Haematol.
2021 Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal J Hematol Oncol.
2021 Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Jordi Esteve Journal Leukemia.
2021 Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission Group Acute Leukemia Working Party (ALWP) 1st listed author Jaime Sanz Journal Bone Marrow Transplant.
2021 Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party Group Acute Leukemia Working Party (ALWP) 1st listed author Klaus Hirschbühl Journal Bone Marrow Transplant.
2021 Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT) Group Acute Leukemia Working Party (ALWP) 1st listed author Francesco Saraceni Journal Cancer Med.
2021 Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Sebastian Giebel Journal Bone Marrow Transplant.